Company Overview:
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases.
Our mission to deliver innovative, life-saving medicines for serious unmet medical conditions drives us every day and contributes to building a sustainable business for the long term. It also inspires our entrepreneurial culture which fosters innovation, collaboration, and a relentless commitment to the people we serve. Patients are at the center of everything we do because everyday matters. Every employee is encouraged to take initiative, explore new ideas, and turn challenges into opportunities that can potentially transform lives, especially those suffering from serious and difficult-to-treat illnesses.
Product to be represented by this role in the U.S.:
- GIAPREZA® (angiotensin II) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.
- XACDURO® (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults.
- XERAVA® (eravacycline) is a broad-spectrum antibiotic used to treat patients with complicated intra-abdominal infections (cIAI).
- ZEVTERA® (ceftobiprole) is an approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis. In addition, Zevtera is approved in adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP).
- NUZOLVENCE® (Zoliflodacin) is a spiropyrimidinetrione bacterial type II topoisomerase inhibitor indicated for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 years of age and older, weighing at least 35 kg. It is the first FDA-approved single-dose oral antibiotic with a novel mechanism of action for uncomplicated urogenital gonorrhea in decades.
SUMMARY OF POSITION
The Clinical Account Manager will lead the launch of NUZOLVENCE, a new product for the treatment of uncomplicated urogenital gonorrhea, with an initial focus on Healthcare Professionals (HCPs) in the Public Health setting within the assigned territory. The Clinical Account Manager will serve as the brand’s primary field face to public health clinics, community health centers, and the clinicians and program leaders who diagnose and treat STIs at scale. In addition, this role will identify and build relationships with select key community HCP leaders and influencers who shape STI care and treatment practices in the territory, laying the groundwork for future commercial opportunities.
As a launch role, core priorities include building disease state and clinical awareness as well as in establishing patient access across various site-specific settings of care. This role will be responsible for establishing Innoviva Specialty Therapeutics as a trusted and valued partner in STI space, working on behalf of patients and physicians. As awareness and utilization expand, the role is expected to scale nationally in public health clinics and will also expand over time to non-public health HCPs and institutions, including private sector practices, health systems, and academic/college health care settings.
RESPONSIBILITIES
Customer engagement, launch execution, and post launch expansion
- Engage public health clinic HCPs and administrators (physicians, nurse practitioners, physician assistants, clinic and program medical directors, pharmacists, and disease intervention specialists) with accurate, balanced, on-label scientific and clinical information about the therapy.
- Execute the launch plan for the territory based on the target list, call plan, and account strategy built around STI clinics, health departments, federally qualified health centers (FQHCs), and family planning and community clinics.
- As the role expands, extend launch execution and account strategy to non-public health HCPs and institutions, including private sector and academic/college health settings, adapting engagement and access approaches to each.
- Identify and map key stakeholders in each account, including prescribers, pharmacy and procurement leads, program managers, and clinical champions, and tailor engagement to each.
- Deliver product education, treatment-guideline context, and resources for clinical staff in group and one-to-one settings, including lunch-and-learns, and in-service presentations, and virtual engagements as permitted by policy.
Access and account management
- Support access and adoption by navigating the operational realities of public health, including formulary and standing-order processes, clinic purchasing, and 340B pricing programs, working alongside Market Access colleagues.
- Partner with wholesalers, specialty distributors, and pharmacy contacts to help ensure product is available at the point of care.
- Connect accounts with patient support, copay, and reimbursement resources and information where available.
Cross-functional collaboration and insight
- Collaborate with Medical Affairs, Market Access, Marketing, Compliance, Legal, and Regulatory; route unsolicited medical questions to Medical Affairs according to company procedure.
- Gather and share field insights on guideline changes, local epidemiological trends, funding shifts, and competitor activity.
- Represent the company at approved public health conferences, state and local STI program meetings, and community events.
Compliance and business management
- Promote only within the approved label and approved promotional materials, and comply with the PhRMA Code, the federal Anti-Kickback Statute, state gift-ban and disclosure laws, and company policy.
- Know and follow each account's vendor-access policy before the call; many government-run sites restrict or prohibit detailing, meals, and materials.
- Maintain complete, timely call documentation in the CRM and expense records; manage the territory budget responsibly.
- Complete all required training, including product, disease-state, and compliance certifications, within required timelines.
EXPERIENCE AND EDUCATION
- Bachelor's degree is required. Advanced degree or relevant certification (for example, MPH) is a plus.
- 3 plus years of pharmaceutical, biotech, or medical sales experience, including at least 1 year of specialty or launch experience.
- Experience in infectious disease, STI, HIV, sexual health, or other anti-infective categories.
- Demonstrated ability to meet or exceed sales and activity goals in a field-based role.
- Knowledge of the public health and safety-net landscape, including health department clinics, FQHCs, and 340B-eligible entities.
- Understanding of the payer landscape, specifically Medicaid, 340b covered entities, Medicare, and influence of other commercial plans/PBMs in patient access.
- Experience calling on non-public health HCPs and institutions, such as private practices, health systems, and academic/college health centers, to support the role’s planned expansion beyond public health.
- Ability to travel within territory, including some overnight travel.
- Residence within or near the assigned territory.
- Prior successful product launch experience preferred, ideally with a government, public-sector, or safety-net customer base.
- Existing relationships with state or local health departments, STI/HIV programs, or community health networks in the territory preferred.
- Familiarity with state and local public procurement, standing orders, and Medicaid or Ryan White program dynamics preferred.
- Experience navigating restricted-access or no-detailing environments preferred.
- Bilingual (English/Spanish) skills are a plus where territory demographics call for it.
SKILLS & ABILITIES
- Understands how government and nonprofit clinics are funded, staffed, and held accountable, and respects their constraints.
- Ability to learn and communicate clinical and epidemiologic information on infectious diseases and apply it credibly with clinicians.
- Strong account-planning, presentation, and relationship-building skills.
- Proficiency with CRM platforms, Microsoft Office, and virtual engagement tools.
- Explains clinical data, resistance trends, and treatment guidelines clearly and accurately without overstating.
- Demonstrates launch agility by working with incomplete information, adapts the plan as access and guidance evolve, and takes initiative.
- Handles sensitive topics related to sexual health with professionalism, empathy, and without stigma.
- Collaborates effectively with colleagues across a small, cross-functional launch team.
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
Innoviva Specialty Therapeutics is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.